Global Critical Care Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 117046
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Critical Care Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Critical Care Therapeutics market size is estimated to be worth US$ 3070.4 million in 2021 and is forecast to a readjusted size of USD 3571.2 million by 2028 with a CAGR of 2.2% during review period. Pulmonary Embolism (PE) accounting for % of the Critical Care Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Albumin segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Critical Care Therapeutics include CSL Behring, Grifols, Kedrion Biopharma, Octapharma, and Takeda, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Critical Care Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Albumin

Prothrombin Complex Concentrates

Antithrombin Concentrates

Factor XIII Concentrates

Fibrinogen Concentrates

Market segment by Application, can be divided into

Pulmonary Embolism (PE)

Acute Coronary Syndrome

Atrial Fibrillation

Other

Market segment by players, this report covers

CSL Behring

Grifols

Kedrion Biopharma

Octapharma

Takeda

Bayer HealthCare

Merck

Mitsubishi Tanabe Pharma

REVO Biologics

Rockwell Medical

Thermo Fisher Scientific

Shanghai RAAS

China Biologic Products

Cosmo Pharmaceuticals

King Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Critical Care Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Critical Care Therapeutics, with revenue, gross margin and global market share of Critical Care Therapeutics from 2019 to 2022.

Chapter 3, the Critical Care Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Critical Care Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Critical Care Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Critical Care Therapeutics

1.2 Classification of Critical Care Therapeutics by Type

1.2.1 Overview: Global Critical Care Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Critical Care Therapeutics Revenue Market Share by Type in 2021

1.2.3 Albumin

1.2.4 Prothrombin Complex Concentrates

1.2.5 Antithrombin Concentrates

1.2.6 Factor XIII Concentrates

1.2.7 Fibrinogen Concentrates

1.3 Global Critical Care Therapeutics Market by Application

1.3.1 Overview: Global Critical Care Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pulmonary Embolism (PE)

1.3.3 Acute Coronary Syndrome

1.3.4 Atrial Fibrillation

1.3.5 Other

1.4 Global Critical Care Therapeutics Market Size & Forecast

1.5 Global Critical Care Therapeutics Market Size and Forecast by Region

1.5.1 Global Critical Care Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Critical Care Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Critical Care Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Critical Care Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Critical Care Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Critical Care Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Critical Care Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Critical Care Therapeutics Market Drivers

1.6.2 Critical Care Therapeutics Market Restraints

1.6.3 Critical Care Therapeutics Trends Analysis

2 Company Profiles

2.1 CSL Behring

2.1.1 CSL Behring Details

2.1.2 CSL Behring Major Business

2.1.3 CSL Behring Critical Care Therapeutics Product and Solutions

2.1.4 CSL Behring Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 CSL Behring Recent Developments and Future Plans

2.2 Grifols

2.2.1 Grifols Details

2.2.2 Grifols Major Business

2.2.3 Grifols Critical Care Therapeutics Product and Solutions

2.2.4 Grifols Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Grifols Recent Developments and Future Plans

2.3 Kedrion Biopharma

2.3.1 Kedrion Biopharma Details

2.3.2 Kedrion Biopharma Major Business

2.3.3 Kedrion Biopharma Critical Care Therapeutics Product and Solutions

2.3.4 Kedrion Biopharma Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Kedrion Biopharma Recent Developments and Future Plans

2.4 Octapharma

2.4.1 Octapharma Details

2.4.2 Octapharma Major Business

2.4.3 Octapharma Critical Care Therapeutics Product and Solutions

2.4.4 Octapharma Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Octapharma Recent Developments and Future Plans

2.5 Takeda

2.5.1 Takeda Details

2.5.2 Takeda Major Business

2.5.3 Takeda Critical Care Therapeutics Product and Solutions

2.5.4 Takeda Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Takeda Recent Developments and Future Plans

2.6 Bayer HealthCare

2.6.1 Bayer HealthCare Details

2.6.2 Bayer HealthCare Major Business

2.6.3 Bayer HealthCare Critical Care Therapeutics Product and Solutions

2.6.4 Bayer HealthCare Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bayer HealthCare Recent Developments and Future Plans

2.7 Merck

2.7.1 Merck Details

2.7.2 Merck Major Business

2.7.3 Merck Critical Care Therapeutics Product and Solutions

2.7.4 Merck Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Merck Recent Developments and Future Plans

2.8 Mitsubishi Tanabe Pharma

2.8.1 Mitsubishi Tanabe Pharma Details

2.8.2 Mitsubishi Tanabe Pharma Major Business

2.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Product and Solutions

2.8.4 Mitsubishi Tanabe Pharma Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans

2.9 REVO Biologics

2.9.1 REVO Biologics Details

2.9.2 REVO Biologics Major Business

2.9.3 REVO Biologics Critical Care Therapeutics Product and Solutions

2.9.4 REVO Biologics Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 REVO Biologics Recent Developments and Future Plans

2.10 Rockwell Medical

2.10.1 Rockwell Medical Details

2.10.2 Rockwell Medical Major Business

2.10.3 Rockwell Medical Critical Care Therapeutics Product and Solutions

2.10.4 Rockwell Medical Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Rockwell Medical Recent Developments and Future Plans

2.11 Thermo Fisher Scientific

2.11.1 Thermo Fisher Scientific Details

2.11.2 Thermo Fisher Scientific Major Business

2.11.3 Thermo Fisher Scientific Critical Care Therapeutics Product and Solutions

2.11.4 Thermo Fisher Scientific Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.12 Shanghai RAAS

2.12.1 Shanghai RAAS Details

2.12.2 Shanghai RAAS Major Business

2.12.3 Shanghai RAAS Critical Care Therapeutics Product and Solutions

2.12.4 Shanghai RAAS Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Shanghai RAAS Recent Developments and Future Plans

2.13 China Biologic Products

2.13.1 China Biologic Products Details

2.13.2 China Biologic Products Major Business

2.13.3 China Biologic Products Critical Care Therapeutics Product and Solutions

2.13.4 China Biologic Products Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 China Biologic Products Recent Developments and Future Plans

2.14 Cosmo Pharmaceuticals

2.14.1 Cosmo Pharmaceuticals Details

2.14.2 Cosmo Pharmaceuticals Major Business

2.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Product and Solutions

2.14.4 Cosmo Pharmaceuticals Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Cosmo Pharmaceuticals Recent Developments and Future Plans

2.15 King Pharmaceuticals

2.15.1 King Pharmaceuticals Details

2.15.2 King Pharmaceuticals Major Business

2.15.3 King Pharmaceuticals Critical Care Therapeutics Product and Solutions

2.15.4 King Pharmaceuticals Critical Care Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 King Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Critical Care Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Critical Care Therapeutics Players Market Share in 2021

3.2.2 Top 10 Critical Care Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Critical Care Therapeutics Players Head Office, Products and Services Provided

3.4 Critical Care Therapeutics Mergers & Acquisitions

3.5 Critical Care Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Critical Care Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Critical Care Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Critical Care Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Critical Care Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Critical Care Therapeutics Revenue by Type (2017-2028)

6.2 North America Critical Care Therapeutics Revenue by Application (2017-2028)

6.3 North America Critical Care Therapeutics Market Size by Country

6.3.1 North America Critical Care Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Critical Care Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Critical Care Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Critical Care Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Critical Care Therapeutics Revenue by Type (2017-2028)

7.2 Europe Critical Care Therapeutics Revenue by Application (2017-2028)

7.3 Europe Critical Care Therapeutics Market Size by Country

7.3.1 Europe Critical Care Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Critical Care Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Critical Care Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Critical Care Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Critical Care Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Critical Care Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Critical Care Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Critical Care Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Critical Care Therapeutics Market Size by Region

8.3.1 Asia-Pacific Critical Care Therapeutics Revenue by Region (2017-2028)

8.3.2 China Critical Care Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Critical Care Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Critical Care Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Critical Care Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Critical Care Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Critical Care Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Critical Care Therapeutics Revenue by Type (2017-2028)

9.2 South America Critical Care Therapeutics Revenue by Application (2017-2028)

9.3 South America Critical Care Therapeutics Market Size by Country

9.3.1 South America Critical Care Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Critical Care Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Critical Care Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Critical Care Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Critical Care Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Critical Care Therapeutics Market Size by Country

10.3.1 Middle East & Africa Critical Care Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Critical Care Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Critical Care Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Critical Care Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Critical Care Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Critical Care Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Critical Care Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Critical Care Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Critical Care Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. CSL Behring Corporate Information, Head Office, and Major Competitors

Table 7. CSL Behring Major Business

Table 8. CSL Behring Critical Care Therapeutics Product and Solutions

Table 9. CSL Behring Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Grifols Corporate Information, Head Office, and Major Competitors

Table 11. Grifols Major Business

Table 12. Grifols Critical Care Therapeutics Product and Solutions

Table 13. Grifols Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Kedrion Biopharma Corporate Information, Head Office, and Major Competitors

Table 15. Kedrion Biopharma Major Business

Table 16. Kedrion Biopharma Critical Care Therapeutics Product and Solutions

Table 17. Kedrion Biopharma Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Octapharma Corporate Information, Head Office, and Major Competitors

Table 19. Octapharma Major Business

Table 20. Octapharma Critical Care Therapeutics Product and Solutions

Table 21. Octapharma Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Takeda Corporate Information, Head Office, and Major Competitors

Table 23. Takeda Major Business

Table 24. Takeda Critical Care Therapeutics Product and Solutions

Table 25. Takeda Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bayer HealthCare Corporate Information, Head Office, and Major Competitors

Table 27. Bayer HealthCare Major Business

Table 28. Bayer HealthCare Critical Care Therapeutics Product and Solutions

Table 29. Bayer HealthCare Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Merck Corporate Information, Head Office, and Major Competitors

Table 31. Merck Major Business

Table 32. Merck Critical Care Therapeutics Product and Solutions

Table 33. Merck Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Mitsubishi Tanabe Pharma Corporate Information, Head Office, and Major Competitors

Table 35. Mitsubishi Tanabe Pharma Major Business

Table 36. Mitsubishi Tanabe Pharma Critical Care Therapeutics Product and Solutions

Table 37. Mitsubishi Tanabe Pharma Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. REVO Biologics Corporate Information, Head Office, and Major Competitors

Table 39. REVO Biologics Major Business

Table 40. REVO Biologics Critical Care Therapeutics Product and Solutions

Table 41. REVO Biologics Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Rockwell Medical Corporate Information, Head Office, and Major Competitors

Table 43. Rockwell Medical Major Business

Table 44. Rockwell Medical Critical Care Therapeutics Product and Solutions

Table 45. Rockwell Medical Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 47. Thermo Fisher Scientific Major Business

Table 48. Thermo Fisher Scientific Critical Care Therapeutics Product and Solutions

Table 49. Thermo Fisher Scientific Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Shanghai RAAS Corporate Information, Head Office, and Major Competitors

Table 51. Shanghai RAAS Major Business

Table 52. Shanghai RAAS Critical Care Therapeutics Product and Solutions

Table 53. Shanghai RAAS Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. China Biologic Products Corporate Information, Head Office, and Major Competitors

Table 55. China Biologic Products Major Business

Table 56. China Biologic Products Critical Care Therapeutics Product and Solutions

Table 57. China Biologic Products Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Cosmo Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 59. Cosmo Pharmaceuticals Major Business

Table 60. Cosmo Pharmaceuticals Critical Care Therapeutics Product and Solutions

Table 61. Cosmo Pharmaceuticals Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. King Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 63. King Pharmaceuticals Major Business

Table 64. King Pharmaceuticals Critical Care Therapeutics Product and Solutions

Table 65. King Pharmaceuticals Critical Care Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Critical Care Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Critical Care Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Critical Care Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Critical Care Therapeutics Players Head Office, Products and Services Provided

Table 70. Critical Care Therapeutics Mergers & Acquisitions in the Past Five Years

Table 71. Critical Care Therapeutics New Entrants and Expansion Plans

Table 72. Global Critical Care Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 73. Global Critical Care Therapeutics Revenue Share by Type (2017-2022)

Table 74. Global Critical Care Therapeutics Revenue Forecast by Type (2023-2028)

Table 75. Global Critical Care Therapeutics Revenue by Application (2017-2022)

Table 76. Global Critical Care Therapeutics Revenue Forecast by Application (2023-2028)

Table 77. North America Critical Care Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Critical Care Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Critical Care Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Critical Care Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Critical Care Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Critical Care Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Critical Care Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Critical Care Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Critical Care Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Critical Care Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Critical Care Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Critical Care Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Critical Care Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Critical Care Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Critical Care Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Critical Care Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Critical Care Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Critical Care Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Critical Care Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Critical Care Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Critical Care Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Critical Care Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Critical Care Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Critical Care Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Critical Care Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Critical Care Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Critical Care Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Critical Care Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Critical Care Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Critical Care Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Critical Care Therapeutics Picture

Figure 2. Global Critical Care Therapeutics Revenue Market Share by Type in 2021

Figure 3. Albumin

Figure 4. Prothrombin Complex Concentrates

Figure 5. Antithrombin Concentrates

Figure 6. Factor XIII Concentrates

Figure 7. Fibrinogen Concentrates

Figure 8. Critical Care Therapeutics Revenue Market Share by Application in 2021

Figure 9. Pulmonary Embolism (PE) Picture

Figure 10. Acute Coronary Syndrome Picture

Figure 11. Atrial Fibrillation Picture

Figure 12. Other Picture

Figure 13. Global Critical Care Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Critical Care Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Critical Care Therapeutics Revenue Market Share by Region (2017-2028)

Figure 16. Global Critical Care Therapeutics Revenue Market Share by Region in 2021

Figure 17. North America Critical Care Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Critical Care Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Critical Care Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Critical Care Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Critical Care Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Critical Care Therapeutics Market Drivers

Figure 23. Critical Care Therapeutics Market Restraints

Figure 24. Critical Care Therapeutics Market Trends

Figure 25. CSL Behring Recent Developments and Future Plans

Figure 26. Grifols Recent Developments and Future Plans

Figure 27. Kedrion Biopharma Recent Developments and Future Plans

Figure 28. Octapharma Recent Developments and Future Plans

Figure 29. Takeda Recent Developments and Future Plans

Figure 30. Bayer HealthCare Recent Developments and Future Plans

Figure 31. Merck Recent Developments and Future Plans

Figure 32. Mitsubishi Tanabe Pharma Recent Developments and Future Plans

Figure 33. REVO Biologics Recent Developments and Future Plans

Figure 34. Rockwell Medical Recent Developments and Future Plans

Figure 35. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 36. Shanghai RAAS Recent Developments and Future Plans

Figure 37. China Biologic Products Recent Developments and Future Plans

Figure 38. Cosmo Pharmaceuticals Recent Developments and Future Plans

Figure 39. King Pharmaceuticals Recent Developments and Future Plans

Figure 40. Global Critical Care Therapeutics Revenue Share by Players in 2021

Figure 41. Critical Care Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 42. Global Top 3 Players Critical Care Therapeutics Revenue Market Share in 2021

Figure 43. Global Top 10 Players Critical Care Therapeutics Revenue Market Share in 2021

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 45. Global Critical Care Therapeutics Revenue Share by Type in 2021

Figure 46. Global Critical Care Therapeutics Market Share Forecast by Type (2023-2028)

Figure 47. Global Critical Care Therapeutics Revenue Share by Application in 2021

Figure 48. Global Critical Care Therapeutics Market Share Forecast by Application (2023-2028)

Figure 49. North America Critical Care Therapeutics Sales Market Share by Type (2017-2028)

Figure 50. North America Critical Care Therapeutics Sales Market Share by Application (2017-2028)

Figure 51. North America Critical Care Therapeutics Revenue Market Share by Country (2017-2028)

Figure 52. United States Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Canada Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Mexico Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Europe Critical Care Therapeutics Sales Market Share by Type (2017-2028)

Figure 56. Europe Critical Care Therapeutics Sales Market Share by Application (2017-2028)

Figure 57. Europe Critical Care Therapeutics Revenue Market Share by Country (2017-2028)

Figure 58. Germany Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. France Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. United Kingdom Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Russia Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Italy Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Asia-Pacific Critical Care Therapeutics Sales Market Share by Type (2017-2028)

Figure 64. Asia-Pacific Critical Care Therapeutics Sales Market Share by Application (2017-2028)

Figure 65. Asia-Pacific Critical Care Therapeutics Revenue Market Share by Region (2017-2028)

Figure 66. China Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Japan Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South Korea Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. India Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Southeast Asia Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Australia Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South America Critical Care Therapeutics Sales Market Share by Type (2017-2028)

Figure 73. South America Critical Care Therapeutics Sales Market Share by Application (2017-2028)

Figure 74. South America Critical Care Therapeutics Revenue Market Share by Country (2017-2028)

Figure 75. Brazil Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Argentina Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Middle East and Africa Critical Care Therapeutics Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Critical Care Therapeutics Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Critical Care Therapeutics Revenue Market Share by Country (2017-2028)

Figure 80. Turkey Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Saudi Arabia Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. UAE Critical Care Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source